TABLE 2.
Laboratory findings of the study population on admission, overall and by vitamin D
| Characteristics | Total | Without vitamin D deficiency | With vitamin D deficiency | p‐value |
|---|---|---|---|---|
| WBC count (×109/L), Median (IQR) | 6.1 (4.6–8.4) | 5.7 (4.3–8.2) | 6.7 (4.9–8.9) | .143 |
| Lymph (×109/L), Median (IQR) | 1.9 (1.3–2.6) | 2.0 (1.4–2.6) | 1.8 (1.2–2.5) | .594 |
| AST (U/L), Median (IQR) | 38.0 (29.0–55.7) | 37.0 (28.0– 53.5) | 38.0 (29.0–63.0) | .996 |
| ALT (U/L), Median (IQR) | 28.0 (19.0–44.7) | 30.0 (19.0–45.0) | 28.0 (19.0–44.0) | .551 |
| Creatinine (mg/dl), Median (IQR) | 1.10 (0.9–1.3) | 1.00 (0.9–1.3) | 1.10 (0.9–1.3) | .584 |
| LDH (U/L), Median (IQR) | 590.5 (469.5–824.7) | 563.5 (481.2–820.3) | 614.0 (454.0–830.5) | .345 |
| Hb (g/dl), Median (IQR) | 13.1 (11.5–14.4) | 13.2 (11.8–14.5) | 12.8 (11.0–14.3) | .209 |
| ESR (mm/h), Median (IQR) | 41.0 (26.5–58.7) | 40.0 (25.0–55.0) | 42.5 (30.0–63.3) | .144 |
| CRP >3+, % (N) | 20.0% (50) | 18.6% (24) | 21.5% (26) | .569 |
| CPK (U/L), Median (IQR) | 163 (75–286) | 170.5 (75.0–287.0) | 145.0 (70.0–274.0) | .823 |
| PT (S), Median (IQR) | 13.5 (13.0–14.00) | 13.5 (13.0–14.45) | 13.5 (13.5–15.40) | .233 |
Abbreviations: ALT, alanine transaminases; AST, aspartate transaminases; CPK, creatine phosphokinase; CRP, C‐reactive protein; ESR, erythrocyte sedimentation rate; Hb, hemoglobin; IQR, interquartile range; LDH, Lactate dehydrogenase; Lymph, lymphocyte count; PT, prothrombin time; WBC, White blood cells.